A Multi-Center, Randomized, Open-Label, Parallel Group Study of FE 999913 Vaginal Tablet 100 mg in Japanese Female Patients Undergoing Fertility Treatment [In Vitro Fertilization/Embryo Transfer (IVF-ET)]
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Progesterone (Primary)
- Indications Infertility
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Apr 2013 Planned End Date changed from 1 Sep 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.